Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Tilray Inc stock logo
TLRY
Tilray
$0.49
-1.0%
$0.60
$0.43
$2.34
$488.25M1.8828.90 million shs27.48 million shs
10 Best Cheap Stocks to Buy Now Cover

MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Enter your email address and below to see which companies made the list.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Tilray Inc stock logo
TLRY
Tilray
-0.96%+9.26%-26.22%-57.07%-80.36%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Tilray Inc stock logo
TLRY
Tilray
1.5736 of 5 stars
3.12.00.00.01.30.01.3
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Tilray Inc stock logo
TLRY
Tilray
2.25
Hold$1.92295.11% Upside

Current Analyst Ratings Breakdown

Latest TLRY Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
4/14/2025
Tilray Inc stock logo
TLRY
Tilray
Roth Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingNeutral ➝ Neutral
4/9/2025
Tilray Inc stock logo
TLRY
Tilray
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetNeutral ➝ Neutral$2.00 ➝ $1.00
(Data available from 5/1/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Tilray Inc stock logo
TLRY
Tilray
$210.48M2.32N/AN/A$4.14 per share0.12
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Tilray Inc stock logo
TLRY
Tilray
-$244.98M-$1.05N/AN/AN/A-30.95%-4.40%-3.57%N/A

Latest TLRY Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
4/8/2025Q3 2025
Tilray Inc stock logo
TLRY
Tilray
-$0.04-$0.10-$0.06-$0.87$213.38 million$185.78 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Tilray Inc stock logo
TLRY
Tilray
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Tilray Inc stock logo
TLRY
Tilray
0.10
2.54
1.58

Institutional Ownership

CompanyInstitutional Ownership
Tilray Inc stock logo
TLRY
Tilray
9.35%

Insider Ownership

CompanyInsider Ownership
Tilray Inc stock logo
TLRY
Tilray
0.87%
CompanyEmployeesShares OutstandingFree FloatOptionable
Tilray Inc stock logo
TLRY
Tilray
2,6501.01 billion929.50 millionOptionable

Recent News About These Companies

Tilray Inc stock logo
Tilray (NASDAQ:TLRY) Trading 0.2% Higher - Still a Buy?
Tilray Inc stock logo
Tilray (NASDAQ:TLRY) Shares Down 3.3% - Time to Sell?
Tilray Brands Could Bounce Big
Widmer Brothers Brewing Celebrates 40th Anniversary
Tilray’s Terrapin Beer partners with Orvis
Tilray Brands Announces Reverse Stock Split

New MarketBeat Followers Over Time

Media Sentiment Over Time

Tilray stock logo

Tilray NASDAQ:TLRY

$0.49 0.00 (-0.96%)
As of 04/30/2025 04:00 PM Eastern

Tilray, Inc. engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc. is headquartered in Canada.